0001193125-18-127926.txt : 20180424 0001193125-18-127926.hdr.sgml : 20180424 20180424094702 ACCESSION NUMBER: 0001193125-18-127926 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20180424 FILED AS OF DATE: 20180424 DATE AS OF CHANGE: 20180424 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Zai Lab Ltd CENTRAL INDEX KEY: 0001704292 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38205 FILM NUMBER: 18770385 BUSINESS ADDRESS: STREET 1: 4560 JINKE ROAD STREET 2: BLDG. 1, 4F, PUDONG CITY: SHANGHAI STATE: F4 ZIP: 201210 BUSINESS PHONE: 862161632588 MAIL ADDRESS: STREET 1: 4560 JINKE ROAD STREET 2: BLDG. 1, 4F, PUDONG CITY: SHANGHAI STATE: F4 ZIP: 201210 6-K 1 d575045d6k.htm FORM 6-K Form 6-K

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 6-K

 

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13A-16 OR 15D-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the Month of April 2018

Commission File Number: 001-38205

 

 

ZAI LAB LIMITED

(Translation of registrant’s name into English)

 

 

4560 Jinke Road, Bldg. 1, 4F, Pudong, Shanghai, China 201210

(Address of principal executive offices)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒                 Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):   ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):   ☐

 

 

 

EXHIBIT INDEX

 

Exhibit No.

   

Description

Exhibit 99.1   

Announcement related to announcement of 2017 financial results

SIGNATURES

Pursuant to the requirements of the Securities Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

ZAI LAB LIMITED
By:   /s/ Billy Cho
Name:   Billy Cho
Title:   Chief Financial Officer

Dated: April 24, 2018

EX-99.1 2 d575045dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

 

LOGO

Zai Lab Limited to Announce Full Year 2017 Financial Results

SHANGHAI, China. April 24, 2018: Zai Lab Limited (NASDAQ: ZLAB), a Shanghai-based innovative biopharmaceutical company, today announced that it will host a conference call and webcast on Wednesday, May 2nd, 2018 at 8:30am ET to discuss financial results for the full year ended December 31, 2017. On the call, Zai Lab’s senior management team will also provide the latest status update on the Company’s various development programs.

Investor Conference Call Details

Date: Wednesday, May 2nd, 2018

Time: 8:30am ET

Dial-In Details: 1-866-394-4355 (US); 1-314-888-4344 (International); 4006828609 (China)

Conference ID: 5836799

A live webcast and replay will be available on the Zai Lab investor website: http://ir.zailaboratory.com.    Please note, on Monday, April 30th, 2018 Zai Lab intends to file its Form 20-F for the Year Ended December 31, 2017.

About Zai Lab

Zai Lab (NASDAQ: ZLAB) is a Shanghai-based innovative biopharmaceutical company focused on bringing transformative medicines for cancer, autoimmune and infectious diseases to patients in China and around the world. The company’s experienced team has secured partnerships with leading global biopharma companies, generating a broad pipeline of innovative drug candidates targeting the fast growing segments of China’s pharmaceutical market and global unmet medical needs. Zai Lab’s vision is to become a fully integrated biopharmaceutical company, discovering, developing, manufacturing and commercializing its partners’ and its own products in order to impact human health worldwide.

******

Contact:

Zai Lab

Billy Cho

+86 137 6151 2501

billy.cho@zailaboratory.com

Solebury Trout

John Graziano

+1 646 378 2942

jgraziano@troutgroup.com

GRAPHIC 3 g575045g0424092115275.jpg GRAPHIC begin 644 g575045g0424092115275.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# @&!@<&!0@'!P<)"0@*#!0-# L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#W^BBB@ HH MHH ***1F55+,0 .I)H 6BHH[JWE;;'/$[>BN":EH&TUN%>1?$_QOJEAK)T;3 M+A[5(D5I98SAV+#( /8 $=*]=KS[Q[\.V\37::C83)%>!0DBR?=<#H?8UC74 MG#W3U@T4%)0]X,ZJ8:IBW+"_#;6VU_(* M***V/)"BBB@ HHHH ***X71KF9_BWKT+2N8EM$VH3P/N]JF4N5KS.FAAW6C. M2=N57_%+]3NJ***HY@HHHH **** ."^+5U<6GA6"2VEDBK_ //_ '7_ 'V:^HKBU@NXQ'<0I*@.0KKD9JG)I.D0Q-+)96JH@+,QC& ! M7-5H.#/#RRRDN4 M41P1EOFD8#_.37@VN^,M9\07+27-VZ1$_+#&<*H^E;?Q6UA]0\7R6@?,-DHC M5?\ :(RQ_P ^E6?AGX)@\02RZGJ*%K*!MB1]I'Z\^PJZDI5)\D=CCR[#8?+L M']=Q"O)Z^>NR1PD5U=PL)8IID(Z,K&NDG\?:O=^&AI=Q<2-+',KQW ;#;0"" MI/?J/RKWT:'I0M_(&GVWE8QM\L8KQGXF^"H- GCU/3D*V5PVUX^T;]>/8_TH MG1G3C=,K"9QA,QKQI5*=I;QOJ4/ .KZC<>.-+BFO9Y(VD.Y67NLZBMS*+6YG:2*VN=L*'H@R1@?D*XGX*_P#(;U/_ *]A_P"A"NH\#_\ (]>,.?\ MEZ_]F:M:+?+#U9Y.;4X>WQ6FT8V^^)Z#11178?)!7,>)O#^LZQ=0R:;KLEA$ MB8:-5/S'/6NGKSK4/$'B;7_$=_I7AL1006#;)IY.I;_(-9U6DK,]#+J=651S MIM+E6KE:RZ=;B_\ "#^*O^AOF_[Y/^-)_P (/XL_Z&^7_OD_XTW^ROB.3_R% M;Q[2M_P _Z7W+_P"1&V.I^(?"GB_3]%UB M^&H6FH?+%*1RK9Q_.G6<$MS\5/$UO#.T$LM@%25>J$A>:I>(XK^+Q1X)CU.5 M);X2_O708!.\8_3%:NCRT;4TKV\R M#_A7OB'_ *&ZY_(_XT?\*]\0_P#0W7/Y'_&O1Z*W]C#^F>1_;.+[K_P&/^1Y M7(? &K::]WJ[ZEI]Y-Y4B29RO3IFO5*\Z^+/_ ![:&._VT?RKT%[B&.58 MGE19&Z*6Y-*G[LI1Z%X]^VP]&NTN:7->RM>STV)**C$\)"$2H1(<(0P^;Z45 ML>2TUN25Y;\6/%WV:W_L"RDQ-*-URRG[J]E_&NW\5>(H/#.@S7\N#(!MAC/\ M;GH*^:[FZFU/49+F[FS+/)NDD;MD]?I7+B:O*N5=3Z;AS+?;5/K-1>[';S?_ M /S.S^&/A3^W=:^WW4>;&S(8@CAW[+_ %->^5P/A[Q9X+\/:+;Z=;:K'MC' MSML;+L>IZ5I_\+(\*?\ 053_ +X;_"G1=.G&UUW_!/ M$?&ZLOC?60W7[4Y_#/%>P?"5XV\#QJF-RSR!_KQ_3%<+\6-%,>K0:]; M9W\ M:Y<#@,!Q^8P?SK*\!>-G\)WLD)>,A.<'%1=W=6VZ%7 MX=_\C[I/_70_^@FNH^-7_(#G6+GALRJ.*3 M32335TU9'GGG?$W_ )X:=^0_QI//^)O_ #[Z?^0_QKT2BM?9?WF>7_:2_P"? M,/N_X)Q&D3>/VU2W&I06(L]X\XKC(7OCGK534/"_B/1_$=YJ_AB>%H[T[Y[> M8\;O7]:]"HH]DFK-LE9E.,W*$(I-6:MH_5'GGVGXF?\ /KI_Z?XTOVGXE_\ M/KI_Z?XUZ%11[+^\RO[27_/F'W?\$\^TOPKK^J^*+77/$\T(-F,P00GC/_ZZ MG\1^%M97Q*/$?ARXC2[>,1S12'AP/_U"NZHH]C&UA?VI7]HJB2LERVM[MNUC MSHW'Q-S_ ,>VG_D/\:/M'Q-_Y]M/_(?XUZ+11[+^\RO[37_/F'W?\$\U'A?Q M5XEUBPG\32V\5G9OY@BA/WC_ ) KL=3TE[S6]/O42,B"*9')ZY8#;^1S6S13 MC32,:V85:DHNR22:22LE?IKDO^%:^ M)_\ GRC_ ._Z?XT45SRP\9.[;/>P^?8C#THTJ<8I+R?^8?\ "M?$_P#SY1_] M_P!/\:/^%:^*/^?*/_O^G^-%%3]5AW9M_K+B_P"6/W/_ #/='T:VU/PS#I6I M0AXVMT1USRK!1R#Z@UXGXH^&VJZ \D\!2ZL0OR0?NR>J9RMCIMWJ5XMK:1;YF. NX#]37=S?";5+?P[YQ"2ZH\R@ M0K( L:8.MWXH>%=7\0:M93:=;K)'% 58F15YW$]S1170J$5!Q/ M"GG.(EC(XEI+KNK4M=VV"BBBK.(**** "BBB@ HHHH **** "BBB@ HHHH __ !V0$! end